Conformational changes relevant to channel activity and folding within the first nucleotide binding domain of the cystic fibrosis transmembrane conductance regulator

Rhea P. Hudson, P. Andrew Chong, Irina I. Protasevich, Robert Vernon, Efrat Noy, Hermann Bihler, Jian Li An, Ori Kalid, Inbal Sela-Culang, Martin Mense, Hanoch Senderowitz, Christie G. Brouillette, Julie D. Forman-Kay

Research output: Contribution to journalArticlepeer-review

40 Scopus citations

Abstract

Deletion of Phe-508 (F508del) in the first nucleotide binding domain (NBD1) of the cystic fibrosis transmembrane conductance regulator (CFTR) leads to defects in folding and channel gating. NMR data on human F508del NBD1 indicate that an H620Q mutant, shown to increase channel open probability, and the dual corrector/potentiator CFFT-001 similarly disrupt interactions between β-strands S3, S9, and S10 and the C-terminal helices H8 and H9, shifting a preexisting conformational equilibrium from helix to coil. CFFT-001 appears to interact with β-strands S3/S9/S10, consistent with docking simulations. Decreases in Tm from differential scanning calorimetry with H620Q or CFFT-001 suggest direct compound binding to a less thermostable state of NBD1. We hypothesize that, in full-length CFTR, shifting the conformational equilibrium to reduce H8/H9 interactions with the uniquely conserved strands S9/S10 facilitates release of the regulatory region from the NBD dimerization interface to promote dimerization and thereby increase channel open probability. These studies enabled by our NMR assignments for F508del NBD1 provide a window into the conformational fluctuations within CFTR that may regulate function and contribute to folding energetics.

Original languageEnglish
Pages (from-to)28480-28494
Number of pages15
JournalJournal of Biological Chemistry
Volume287
Issue number34
DOIs
StatePublished - 17 Aug 2012

Fingerprint

Dive into the research topics of 'Conformational changes relevant to channel activity and folding within the first nucleotide binding domain of the cystic fibrosis transmembrane conductance regulator'. Together they form a unique fingerprint.

Cite this